Immunoinformatics Market: Global Key Players, Trends, Share, Industry Size, Growth, Opportunities, Forecast To 2024
May 28, 2019 7:00 AM ET
Summary
WiseGuyReports.com adds “Immunoinformatics Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.
Immunoinformatics is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field’s main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
In 2018, the global Immunoinformatics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Immunoinformatics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunoinformatics development in United States, Europe and China.
The key players covered in this study
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co
Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4067093-global-immunoinformatics-market-size-status-and-forecast-2019-2025
Market segment by Type, the product can be split into
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling
Market segment by Application, split into
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology Of Immune Epitopes
Immune Epitope Database
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Immunoinformatics status, future forecast, growth opportunity, key market and key players.
To present the Immunoinformatics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Immunoinformatics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Complete Report details @ https://www.wiseguyreports.com/reports/4067093-global-immunoinformatics-market-size-status-and-forecast-2019-2025
Major Key Points in Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immunoinformatics Market Size Growth Rate by Type (2014-2025)
1.4.2 Cancer Diagnosis & Therapy
1.4.3 Reverse Vaccinology
1.4.4 Immune System Modeling
1.5 Market by Application
1.5.1 Global Immunoinformatics Market Share by Application (2014-2025)
1.5.2 Allergy Prediction Databases
1.5.3 Analysis Resource Database
1.5.4 International Immunogenetics System
1.5.5 The Ontology Of Immune Epitopes
1.5.6 Immune Epitope Database
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Immunoinformatics Market Size
2.2 Immunoinformatics Growth Trends by Regions
2.2.1 Immunoinformatics Market Size by Regions (2014-2025)
2.2.2 Immunoinformatics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
….
12 International Players Profiles
12.1 EpiVax
12.1.1 EpiVax Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immunoinformatics Introduction
12.1.4 EpiVax Revenue in Immunoinformatics Business (2014-2019)
12.1.5 EpiVax Recent Development
12.2 Novozymes Biopharma
12.2.1 Novozymes Biopharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immunoinformatics Introduction
12.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2014-2019)
12.2.5 Novozymes Biopharma Recent Development
12.3 ioGenetics
12.3.1 ioGenetics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immunoinformatics Introduction
12.3.4 ioGenetics Revenue in Immunoinformatics Business (2014-2019)
12.3.5 ioGenetics Recent Development
12.4 International Society of Vaccines
12.4.1 International Society of Vaccines Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immunoinformatics Introduction
12.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2014-2019)
12.4.5 International Society of Vaccines Recent Development
12.5 IMGT
12.5.1 IMGT Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immunoinformatics Introduction
12.5.4 IMGT Revenue in Immunoinformatics Business (2014-2019)
12.5.5 IMGT Recent Development
12.6 Dassault Systemes
12.6.1 Dassault Systemes Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immunoinformatics Introduction
12.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2014-2019)
12.6.5 Dassault Systemes Recent Development
12.7 Certara
12.7.1 Certara Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immunoinformatics Introduction
12.7.4 Certara Revenue in Immunoinformatics Business (2014-2019)
12.7.5 Certara Recent Development
12.8 Chemical Computing Group
12.8.1 Chemical Computing Group Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immunoinformatics Introduction
12.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2014-2019)
12.8.5 Chemical Computing Group Recent Development
12.9 Compugen
12.9.1 Compugen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immunoinformatics Introduction
12.9.4 Compugen Revenue in Immunoinformatics Business (2014-2019)
12.9.5 Compugen Recent Development
12.10 Genedata AG
12.10.1 Genedata AG Company Details
12.10.2 Company Description and Business Overview
12.10.3 Immunoinformatics Introduction
12.10.4 Genedata AG Revenue in Immunoinformatics Business (2014-2019)
12.10.5 Genedata AG Recent Development
12.11 Insilico Biotechnology AG
12.12 Leadscope Inc
12.13 Nimbus Discovery
12.14 Strand Life Sciences
12.15 Schrodinger
12.16 Simulation Plus
12.17 Rosa & Co
Continued….
Contact Information:
Contact Us:
[email protected]
Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)
Tags:
Research, Research Newswire, English